ConductScience.org, home

Paper277241

A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).

Reddy EK. Br J Cancer Suppl, 1978. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582). Papers, record 277241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/277241

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).
PubMed
Journal
Br J Cancer Suppl
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reddy EKE K

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrosarcomaMajor topic
NitroimidazolesMajor topic
Radiation-Sensitizing AgentsMajor topic
Animals
Male
Radiotherapy Dosage
Rats
Sarcoma, Experimental
Time Factors

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
214068487HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION.Biochem Biophys Res Commun1963https://conductscience.org/library/papers/14068487PubMed
3977399Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.Int J Radiat Oncol Biol Phys1976https://conductscience.org/library/papers/977399PubMed
41109652Proceedings: Radiosensitization of hypoxic cells in solid tumours in mice.Br J Radiol1975https://conductscience.org/library/papers/1109652PubMed
54451633Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.Br J Cancer1974https://conductscience.org/library/papers/4451633PubMed
64507330Preferential sensitization of hypoxic cells to radiation in vivo.Nat New Biol1972https://conductscience.org/library/papers/4507330PubMed
71276030Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.Br J Cancer1976https://conductscience.org/library/papers/1276030PubMed
84622677Radiosensitization of bacterial spores by ketonic agents of differing electron-affinities.Int J Radiat Biol Relat Stud Phys Chem Med1972https://conductscience.org/library/papers/4622677PubMed
9776494Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.Clin Radiol1976https://conductscience.org/library/papers/776494PubMed
10776493Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.Clin Radiol1976https://conductscience.org/library/papers/776493PubMed
11959489Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.Radiat Res1976https://conductscience.org/library/papers/959489PubMed
121277732Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin.Clin Radiol1976https://conductscience.org/library/papers/1277732PubMed
131276579Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.Br J Radiol1976https://conductscience.org/library/papers/1276579PubMed
141257411The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.Radiat Res1976https://conductscience.org/library/papers/1257411PubMed
155666786The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. II. Fractionation: recovery and reoxygenation.Br J Radiol1968https://conductscience.org/library/papers/5666786PubMed
1610881705Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.Radiat Res1974https://conductscience.org/library/papers/10881705PubMed
1710881704Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.Radiat Res1974https://conductscience.org/library/papers/10881704PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/277241

GET https://conductscience.org/api/papers/v1/277241/authors